<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Tue, 21 Apr 2026 10:09:12 -0400--><rss version="2.0">
    <channel>
        <title>Carrick Therapeutics, Inc. () In The News</title>
        <link>https://www.carricktherapeutics.com/news-media/in-the-news/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/carricktherapeutics/files/theme/images/logo-sm.png</url>
                <title>Carrick Therapeutics, Inc. Logo</title>
                <link>https://www.carricktherapeutics.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[OncologyTube Interview: Samuraciclib + Elacestrant Phase 2 Trial in Breast Cancer]]></title>
                <description><![CDATA[]]></description>
                <link>https://oncologytube.com/carrick-therapeutics-samuraciclib-elacestrant-phase-2-trial-in-breast-cancer/</link>
                <pubDate>Fri, 03 Nov 23 00:00:00 -0400</pubDate>
                <guid>https://oncologytube.com/carrick-therapeutics-samuraciclib-elacestrant-phase-2-trial-in-breast-cancer/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Team that discovered and led the early development of samuraciclib have been named winners of the Royal Society of Chemistry's Malcolm Campbell Memorial Prize 2023]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.rscbmcs.org/wp-content/uploads/2023/03/Malcolm_Campbell_Prize_Winners_Annoucement2023.pdf</link>
                <pubDate>Fri, 31 Mar 23 00:00:00 -0400</pubDate>
                <guid>https://www.rscbmcs.org/wp-content/uploads/2023/03/Malcolm_Campbell_Prize_Winners_Annoucement2023.pdf</guid>
                                                                            </item>
            </channel>
</rss>